Radiotherapy is the main treatment modality for prostate cancer. This study investigated the role of TGF-beta 1 in biological sequelae and tumor regrowth following irradiation, which are critical for the clinical radiation response of prostate cancer. Human and murine prostate cancer cell lines, and corresponding hormone-refractory (HR) cells, were used to examine the radiation response by clonogenic assays in vitro and tumor growth delay in vivo. Biological changes after irradiation, including cell death and tumor regrowth, were examined by experimental manipulation of TGF-beta 1 signaling. The correlations among tumor radiation responses, TGF-beta 1 levels, and regulatory T cells (Tregs) recruitment were also evaluated using animal experiments. HR prostate cancer cells appeared more radioresistant and had higher expression of TGF-beta 1 compared to hormone-sensitive (HS) cells. TGF-beta 1 expression was positively linked to irradiation and radioresistance, as demonstrated by in vitro and in vivo experiments. Inhibition of TGF-beta 1 increased tumor inhibition and DNA damage after irradiation. When mice were irradiated with a sub-lethal dose, the regrowth of irradiated tumors was significantly correlated with TGF-beta 1 levels and Tregs accumulation in vivo. Furthermore, blocking TGF-beta 1 clearly attenuated Tregs accumulation and tumor regrowth following treatment. These data demonstrate that TGF-beta 1 is important in determining the radiation response of prostate cancer, including tumor cell killing and the tumor microenvironment. Therefore, concurrent treatment with a TGF-beta 1 inhibitor is a potential therapeutic strategy for increasing the radiation response of prostate cancer, particularly for more aggressive or HR cancer cells. aEuro cent HR prostate cancer cells appeared more radioresistant and had higher expression of TGF-beta 1. aEuro cent TGF-beta 1 was positively linked to the radiation resistance of prostate cancer. aEuro cent Tumor regrowth following irradiation was significantly correlated with TGF-beta 1 and Tregs levels. aEuro cent Blocking TGF-beta 1 significantly attenuated RT-induced DNA repair and Tregs. aEuro cent TGF-beta 1 inhibitor increases the radiation response of HR cancer cells.
机构:
Med Univ Vienna, Div Resp Med, Dept Internal Med 2, Vienna, AustriaMed Univ Vienna, Div Resp Med, Dept Internal Med 2, Vienna, Austria
Lambers, Christopher
Roth, Michael
论文数: 0引用数: 0
h-index: 0
机构:
Univ Basel, Univ Hosp, Dept Biomed Internal Med, Basel, SwitzerlandMed Univ Vienna, Div Resp Med, Dept Internal Med 2, Vienna, Austria
Roth, Michael
Zhong, Jun
论文数: 0引用数: 0
h-index: 0
机构:
Univ Basel, Univ Hosp, Dept Biomed Internal Med, Basel, SwitzerlandMed Univ Vienna, Div Resp Med, Dept Internal Med 2, Vienna, Austria
Zhong, Jun
Campregher, Christoph
论文数: 0引用数: 0
h-index: 0
机构:
Med Univ Vienna, Dept Med, Div Gastroenterol & Hepatol, Christian Doppler Lab Mol Canc Chemoprevent, Vienna, AustriaMed Univ Vienna, Div Resp Med, Dept Internal Med 2, Vienna, Austria
Campregher, Christoph
Binder, Petra
论文数: 0引用数: 0
h-index: 0
机构:
Med Univ Vienna, Div Resp Med, Dept Internal Med 2, Vienna, AustriaMed Univ Vienna, Div Resp Med, Dept Internal Med 2, Vienna, Austria
Binder, Petra
Burian, Bernhard
论文数: 0引用数: 0
h-index: 0
机构:
Med Univ Vienna, Div Resp Med, Dept Internal Med 2, Vienna, AustriaMed Univ Vienna, Div Resp Med, Dept Internal Med 2, Vienna, Austria
Burian, Bernhard
Petkov, Ventzislav
论文数: 0引用数: 0
h-index: 0
机构:
Med Univ Vienna, Div Resp Med, Dept Internal Med 2, Vienna, AustriaMed Univ Vienna, Div Resp Med, Dept Internal Med 2, Vienna, Austria
Petkov, Ventzislav
Block, Lutz-Henning
论文数: 0引用数: 0
h-index: 0
机构:
Med Univ Vienna, Div Resp Med, Dept Internal Med 2, Vienna, AustriaMed Univ Vienna, Div Resp Med, Dept Internal Med 2, Vienna, Austria